Biogen Inc. buy Needham & Company LLC
Start price
26.10.23
/
50%
€229.60
Target price
26.10.24
€289.60
Performance (%)
-26.20%
End price
27.10.24
€169.45
Summary
This prediction ended on 27.10.24 with a price of €169.45. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.20%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -3.027% | -3.027% | 29.575% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten